AstraZeneca Brings Rare Disease Portfolio for Patients in India
AstraZeneca India made its entry into the treatment of rare diseases in India on Tuesday. The company’s ‘Selumetinib’ for Indian patients has been approved by regulators. Regarding rare diseases, there is neither a precise estimation of the rate of mortality or morbidity in India nor an understanding of the disease burden on the public healthcare […]
Continue Reading